血管紧张素转换酶抑制剂(ACEI)用于治疗原发性高血压、充血性心力衰竭、心绞痛、冠心病、心肌梗死等有良好的效果,并且占有很重要的地位。但其不良反应也日渐显现。1方法收集了近10年来国内医药杂志报道的ACEI引起的药物不良反应(ADR)资料11例,其中男6例,占55.5%;女5例,占44.5% Angiotensin converting enzyme inhibitors (ACEI) for the treatment of essential hypertension, congestive heart failure, angina pectoris, coronary heart disease, myocardial infarction, etc. have good results, and occupy a very important position. But its adverse reactions are also increasingly apparent. 1 method collected in the past 10 years reported in the domestic medical journal ACEI-induced adverse drug reactions (ADR) data in 11 cases, of which 6 males, accounting for 55.5%; 5 females, accounting for 44.5%